PAP 2023: Corey Ford Discusses Questions from the State of the Industry Address at Access PAP 2023

A study explores the cost-effectiveness of combining methotrexate with various drugs as a way to combat failed methotrexate monotherapy.

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

An economic evaluation study assesses these costs by therapeutic class, while identifying trends in pharma R&D intensity over time.

An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.

A cross-sectional study evaluates the difference in clinical outcomes and demographics between pediatric RSV patients during these multiple timeframes.

A cross-sectional audit study determines how racial and ethnic disparities—among English, Mandarin, and Spanish-speaking patients—can impact access.